Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BELIEF: Belinostat in Relapsed/Refractory PTCL
NCT00865969Phase 2Completed
- Sponsor
- Spectrum Pharmaceuticals, Inc.
- Start
- Dec 2008
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of belinostat in peripheral T-cell lymphoma (PTCL), sponsored by Spectrum Pharmaceuticals, Inc.. Started Dec 2008; status: completed.
02
Drugs
belinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00865969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00865969.